dc.contributor.author | Taş, T. | |
dc.contributor.author | Çakıroğlu, B. | |
dc.contributor.author | Arda, E. | |
dc.contributor.author | Onuk, Ö. | |
dc.contributor.author | Nuhoğlu, B. | |
dc.date.accessioned | 2021-12-21T08:40:32Z | |
dc.date.available | 2021-12-21T08:40:32Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 20501161 | |
dc.identifier.uri | https://doi.org/10.1016/j.esxm.2020.100313 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1043 | |
dc.description.abstract | Introduction: Platelet-rich plasma (PRP) is useful in the treatment of different conditions and diseases as it contains concentrated levels of many growth factors. Aim: The aim of this study was to investigate the effectiveness of autologous PRP applicati | |
dc.language.iso | English | |
dc.publisher | Elsevier B.V. | |
dc.rights | All Open Access, Gold, Green | |
dc.title | Early Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction | |
dc.type | Article | |
dc.relation.journal | Sexual Medicine | |
dc.identifier.issue | 2 | |
dc.identifier.volume | 9 | |
dc.identifier.doi | 10.1016/j.esxm.2020.100313 | |
dc.relation.issue | 2 | |
dc.relation.volume | 9 | |